Alkylating agents: all 3,295 studies that test it
Page 29 of 33. Open to participants first (456), then studies with results posted, then the rest; newest registration first within each.
- Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic CancerCompletedNCT00255710Phase 1
- Melphalan With BBBD in Treating Patients With Brain MalignanciesTerminatedNCT00253721Phase 1
- Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed GliomasCompletedNCT00253487Not applicable
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal RhabdomyosarcomaStatus unknownNCT00245141Phase 2
- Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal RhabdomyosarcomaStatus unknownNCT00245089Phase 2
- Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00244946Phase 1
- Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.Status unknownNCT00244127Phase 2
- Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell LymphomaCompletedNCT00242996Phase 2
- Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple SclerosisCompletedNCT00241254Phase 3
- Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma MultiformeTerminatedNCT00238277Phase 2
- Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain MetastasesCompletedNCT00238251Phase 2
- Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain TumorsTerminatedNCT00238173Phase 1
- High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF IICompletedNCT00231582Phase 2
- IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell ImmunodeficiencyCompletedNCT00228852Phase 1/2
- Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu VaccineCompletedNCT00228358Phase 1
- Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant MelanomaStatus unknownNCT00226473Phase 4
- Combination Chemotherapy +/- Radiation in High Risk Hodgkin's DiseaseTerminatedNCT00225173Phase 2
- Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's LymphomaCompletedNCT00210379Phase 2
- Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic MalignanciesCompletedNCT00208923Phase 2
- Biologic Correlative Taxotere/ACCompletedNCT00206466Phase 2
- Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone InvolvementCompletedNCT00206388Phase 1
- Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance TherapyCompletedNCT00205764Phase 3
- Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)CompletedNCT00204646Phase 2
- Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)CompletedNCT00204620Phase 2
- Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach CancerCompletedNCT00201747Phase 2
- Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic LeukemiaCompletedNCT00201721Phase 2
- Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast CancerCompletedNCT00201708Phase 2
- A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal CarcinomaCompletedNCT00201396Phase 3
- German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)CompletedNCT00198991Phase 4
- German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00198978Phase 4
- Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast CancerCompletedNCT00194766Phase 2
- Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell LymphomaCompletedNCT00193505Phase 2
- Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast CancerCompletedNCT00193115Phase 2
- Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast CancerCompletedNCT00193011Phase 3
- High Dose CHOP in LymphomaCompletedNCT00192764Phase 2
- A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder CancerCompletedNCT00192049Phase 2
- Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein PurpuraCompletedNCT00190229Not applicable
- Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)CompletedNCT00188136Phase 2
- Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHLCompletedNCT00187161Phase 2
- Treatment for Patients With Stage III or IV Non-Hodgkin LymphomaCompletedNCT00187122Not applicable
- Large Cell Lymphoma Pilot Study IIICompletedNCT00187070Not applicable
- Study for Treatment of Cancer in Children With Ataxia-telangiectasiaCompletedNCT00187057Not applicable
- Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaTerminatedNCT00187005Phase 3
- Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid LeukemiaCompletedNCT00186966Phase 3
- Therapy for Children With Advanced Stage High Risk NeuroblastomaCompletedNCT00186849Phase 2
- Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell DiseaseCompletedNCT00186810Phase 2
- Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic AnemiaCompletedNCT00186797Not applicable
- Intensified Post Remission Therapy Containing PEG-AsparaginaseCompletedNCT00184041Phase 2
- Radiation Therapy or Temozolomide in Treating Patients With GliomasCompletedNCT00182819Phase 3
- High Risk Primitive Neuroectodermal (PNET) Brain Tumors in ChildhoodStatus unknownNCT00180791Phase 2
- Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCCCompletedNCT00173862Phase 2
- Preference Study With Elderly Patients Recurrent Ovarian CancerCompletedNCT00170690Phase 3
- Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)Status unknownNCT00168922Phase 2
- Study of Metastatic Ocular MelanomaStatus unknownNCT00168870Phase 2
- A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive CancerCompletedNCT00165451Phase 2
- Prolonged Daily Temozolomide for Low-Grade GliomaCompletedNCT00165360Phase 2
- Thalidomide in Combination With Temodar in Patients With Neuroendocrine TumorsCompletedNCT00165230Phase 2
- The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine SarcomasStatus unknownNCT00162721Phase 3
- Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich SyndromeCompletedNCT00160355Phase 1
- Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic StudyStatus unknownNCT00156858Not applicable
- Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and LymphomasCompletedNCT00152126Not applicable
- Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)TerminatedNCT00151736Phase 2
- Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and AdolescentsCompletedNCT00147160Phase 2
- Cytoxan, Epirubicin and Capecitabine in Women With Breast CancerCompletedNCT00146588Not applicable
- Osteosarcoma1999-A Study Of Intensive Chemotherapy for OsteosarcomaCompletedNCT00145639Phase 2
- Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to RituximabCompletedNCT00139841Phase 3
- Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic MelanomaTerminatedNCT00138229Phase 2
- Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00138216Phase 1
- Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine TumorsCompletedNCT00137774Phase 2
- Treatment of Patients With Idiopathic Membranous NephropathyCompletedNCT00135954Phase 3
- Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.Status unknownNCT00131313Phase 4
- Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)Status unknownNCT00131053Phase 2
- MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological MalignanciesStatus unknownNCT00129155Phase 2
- Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00128700Phase 1/2
- Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)CompletedNCT00128037Phase 2
- Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell TumorsStatus unknownNCT00127049Phase 2
- Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's LymphomaTerminatedNCT00126243Phase 2
- A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast CancerCompletedNCT00124111Phase 2
- Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)CompletedNCT00115414Phase 2
- Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00112567Phase 1/2
- Temozolomide and Topotecan in Treating Patients With Primary CNS LymphomaWithdrawnNCT00109798Not applicable
- S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00104988Phase 2
- Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal CancerCompletedNCT00103298Phase 2
- Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with TemozolomideActive, not recruitingNCT00102648Phase 1
- Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00099125Phase 2
- Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory LeukemiasCompletedNCT00098436Phase 1
- Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerCompletedNCT00096083Phase 2
- Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)CompletedNCT00094380Phase 1/2
- Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast CancerCompletedNCT00093834Phase 1
- MRI Sarcoma Non Invasive ThermometryCompletedNCT00093509Phase 1/2
- N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant NeuroblastomaCompletedNCT00093353Phase 1
- Use of Busulfan as Conditioning Agent for a Second Stem Cell TransplantCompletedNCT00092937Phase 1
- Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
- Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic MelanomaCompletedNCT00091104Phase 1
- A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00089726Phase 2
- Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the LiverCompletedNCT00089401Phase 2
- Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic AmyloidosisCompletedNCT00089167Phase 2
- Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid TumorsTerminatedNCT00086970Phase 1
- Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00086879Phase 2
- Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerWithdrawnNCT00085449Phase 1/2